These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21878750)

  • 1. Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer.
    Rosca EV; Koskimaki JE; Pandey NB; Wolff AC; Popel AS
    Cancer Biol Ther; 2011 Nov; 12(9):808-17. PubMed ID: 21878750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
    Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
    Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.
    Koskimaki JE; Lee E; Chen W; Rivera CG; Rosca EV; Pandey NB; Popel AS
    Angiogenesis; 2013 Jan; 16(1):159-70. PubMed ID: 23053781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.
    Koskimaki JE; Karagiannis ED; Rosca EV; Vesuna F; Winnard PT; Raman V; Bhujwalla ZM; Popel AS
    Neoplasia; 2009 Dec; 11(12):1285-91. PubMed ID: 20019836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer.
    Rosca EV; Penet MF; Mori N; Koskimaki JE; Lee E; Pandey NB; Bhujwalla ZM; Popel AS
    PLoS One; 2014; 9(11):e111901. PubMed ID: 25384034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasculature-specific MRI reveals differential anti-angiogenic effects of a biomimetic peptide in an orthotopic breast cancer model.
    Kim E; Lee E; Plummer C; Gil S; Popel AS; Pathak AP
    Angiogenesis; 2015 Apr; 18(2):125-36. PubMed ID: 25408417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.
    Koskimaki JE; Karagiannis ED; Tang BC; Hammers H; Watkins DN; Pili R; Popel AS
    BMC Cancer; 2010 Feb; 10():29. PubMed ID: 20122172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
    Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
    Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity.
    Rivera CG; Rosca EV; Pandey NB; Koskimaki JE; Bader JS; Popel AS
    J Med Chem; 2011 Oct; 54(19):6492-500. PubMed ID: 21866962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV.
    Weckmann M; Moir LM; Heckman CA; Black JL; Oliver BG; Burgess JK
    J Cell Mol Med; 2012 Dec; 16(12):3062-73. PubMed ID: 22998238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.
    Rosca EV; Lal B; Koskimaki JE; Popel AS; Laterra J
    Anticancer Drugs; 2012 Aug; 23(7):706-12. PubMed ID: 22495619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nitroxoline on angiogenesis and growth of human bladder cancer.
    Shim JS; Matsui Y; Bhat S; Nacev BA; Xu J; Bhang HE; Dhara S; Han KC; Chong CR; Pomper MG; So A; Liu JO
    J Natl Cancer Inst; 2010 Dec; 102(24):1855-73. PubMed ID: 21088277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo.
    Zibara K; Awada Z; Dib L; El-Saghir J; Al-Ghadban S; Ibrik A; El-Zein N; El-Sabban M
    Sci Rep; 2015 Jul; 5():12598. PubMed ID: 26218768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of recombinant anti-angiogenic peptide of tumstatin on growth and metastasis of human ovarian cancer transplanted in nude mice].
    Zhang GM; Sui LH; Jia T; Zhao YZ; Fu SB; Liu XH; Yu Y
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):170-3. PubMed ID: 18756929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts.
    Roland CL; Dineen SP; Lynn KD; Sullivan LA; Dellinger MT; Sadegh L; Sullivan JP; Shames DS; Brekken RA
    Mol Cancer Ther; 2009 Jul; 8(7):1761-71. PubMed ID: 19567820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model.
    Kim J; Choi SH; Ham SJ; Cho YC; Lee SI; Kang J; Woo DC; Lee WS; Yoo JS; Kim KW; Choi Y
    PLoS One; 2018; 13(1):e0187063. PubMed ID: 29370209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach.
    Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B
    Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.